SEC Form 4/A · accession 0001140361-17-038683
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Henry J Fuchs
Officer — President, Worldwide R&D
Period of report
Mar 3, 2015
Accepted (ET)
Oct 13, 2017 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2015 | J | 0 | $0.00 | A | 88,515 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 5, 2015, the reporting person filed a Form 4 which inadvertently reported an incorrect total amount of securities beneficially owned following the reported transaction. This amendment corrects such total.